HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C J O'Callaghan Selected Research

Infections

7/2012Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo.
10/2000Comparison of cryotherapy with curettage in the treatment of Bowen's disease: a prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C J O'Callaghan Research Topics

Disease

5Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 01/2011
3Cardiovascular Diseases (Cardiovascular Disease)
11/2006 - 03/2006
2Neoplasms (Cancer)
12/2017 - 08/2006
2Colonic Neoplasms (Colon Cancer)
07/2015 - 03/2013
2Pain (Aches)
07/2012 - 10/2000
2Infections
07/2012 - 10/2000
1Neoplasm Metastasis (Metastasis)
02/2024
1Exanthema (Rash)
04/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2012
1Acromegaly
11/2006
1Atherosclerosis
11/2006
1Breast Neoplasms (Breast Cancer)
08/2006
1Menstruation Disturbances
03/2006
1Pathologic Processes
03/2006
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
03/2006
1Peste-des-Petits-Ruminants
01/2004
1Rinderpest (Cattle Plague)
01/2004
1Foot-and-Mouth Disease
01/2004
1Bluetongue
01/2004
1Renal Artery Obstruction (Renal Artery Stenosis)
08/2001
1Hypertension (High Blood Pressure)
08/2001
1Atherosclerotic Plaque (Atheroma)
08/2001
1Pathologic Constriction (Stenosis)
08/2001
1Renovascular Hypertension (Goldblatt Syndrome)
08/2001
1Essential Hypertension
08/2001
1Bowen's Disease (Disease, Bowen)
10/2000
1Hypoxia (Hypoxemia)
03/2000

Drug/Important Bio-Agent (IBA)

4Cetuximab (Erbitux)FDA Link
07/2015 - 01/2011
3Biomarkers (Surrogate Marker)IBA
02/2024 - 02/2014
3Matrix Metalloproteinases (MMPs)IBA
11/2006 - 03/2006
2Monoclonal AntibodiesIBA
02/2024 - 12/2017
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
11/2006 - 03/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2006 - 03/2000
1ErbB Receptors (EGF Receptor)IBA
12/2017
1EpiregulinIBA
02/2014
1Sodium Glutamate (Accent)IBA
03/2013
1Fluorouracil (Carac)FDA LinkGeneric
03/2013
1GemcitabineFDA Link
07/2012
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2012
1pegvisomantFDA LinkGeneric
11/2006
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2006
1AntibodiesIBA
01/2004
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
08/2001
1Antihypertensive Agents (Antihypertensives)IBA
08/2001
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2001
1Angiotensin Receptor AntagonistsIBA
08/2001
1CreatinineIBA
08/2001
1NitrogenIBA
10/2000
1Anti-Bacterial Agents (Antibiotics)IBA
10/2000
1Glucose (Dextrose)FDA LinkGeneric
03/2000

Therapy/Procedure

5Therapeutics
02/2024 - 08/2001
4Drug Therapy (Chemotherapy)
02/2024 - 03/2013
1Aftercare (After-Treatment)
11/2006
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
08/2006
1Contraindications
08/2001
1Curettage
10/2000
1Cautery
10/2000
1Cryotherapy (Therapy, Cold)
10/2000